Efficacy of teclistamab in patients (pts) with heavily pretreated, relapsed/refractory multiple myeloma (RRMM), including those refractory to penta RRMM and BCMA (B-cell maturation antigen) directed therapy (BDT)

被引：0

作者：

Venkatesh, Priyanka

Atrash, Shebli

Paul, Barry

Alkharabsheh, Omar

Afrough, Aimaz

Mahmoudjafari, Zahra

Mushtaq, Muhammad Umair

Hashmi, Hamza

Davis, James A.

Abdallah, Al-Ola A.

机构：

[1] Univ Kansas, Med Ctr, Kansas City, KS USA

[2] Levine Canc Inst, Charlotte, NC USA

[3] Univ S Alabama, Mitchell Canc Inst, Mobile, AL USA

[4] UT Southwestern Med Ctr, Dallas, TX USA

[5] Univ Kansas, Ctr Canc, Westwood, KS USA

[6] Med Univ South Carolina, Charleston, SC USA

[7] Univ Kansas, US Myeloma Res Innovat Res Collaborat USMIRC, Med Ctr, Westwood, KS USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e20044

引用

页数：1